/PRNewswire/ Polpharma Biologics, an international biotech company dedicated to the development and manufacturing of biosimilars, today announced topline.
BASEL, Switzerland, August 03, 2023 / B3C newswire / Celonic Group, a Swiss-based Biologics Contract Development and Manufacturing Organization (CDMO), has appointed Dr. Samanta Cimitan as the Chief Executive Officer (CEO) of the Celonic Group, a subsidiary of the independent and privately owned J.RETTENMAIER &am.
BASEL, Switzerland, June 01, 2022 / B3C newswire / Celonic Group, a Swiss-German contract development and manufacturing organization (CDMO), has appointed Dr. Samanta Cimitan as the Chief Business Officer (CBO) of Celonic Group.With more than 20 years’ experience working, teaching, and studying in Life Sciences,.
HEIDELBERG, Germany, March 24, 2022 / B3C newswire / The Federal Republic of Germany has announced its decision to sign contracts with Celonic AG and four other partners to secure the long-term supply of vaccines in Germany against Covid-19 and other pandemics. Celonic will provide the capacity and the expertise.